210 related articles for article (PubMed ID: 26777041)
41. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
42. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
43. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
[TBL] [Abstract][Full Text] [Related]
44. Final height in patients with idiopathic short stature and high growth hormone responses to stimulation tests.
Martinelli CE; Sader Milani S; Previato JK; Figueira M; Rangel Montenegro AP; Miraki-Moud F; Betancourth S; Moreira AC; Savage MO; Camacho-Hübner C
Horm Res; 2007; 67(5):224-30. PubMed ID: 17135759
[TBL] [Abstract][Full Text] [Related]
45. Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review.
Deodati A; Cianfarani S
BMJ; 2011 Mar; 342():c7157. PubMed ID: 21398350
[TBL] [Abstract][Full Text] [Related]
46. Growth hormone for short children--whom should we be treating and why?
Kelnar CJ
J R Coll Physicians Edinb; 2012 Mar; 42(1):32-3. PubMed ID: 22441061
[TBL] [Abstract][Full Text] [Related]
47. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
[TBL] [Abstract][Full Text] [Related]
48. Neural network models - a novel tool for predicting the efficacy of growth hormone (GH) therapy in children with short stature.
Smyczynska J; Hilczer M; Smyczynska U; Stawerska R; Tadeusiewicz R; Lewinski A
Neuro Endocrinol Lett; 2015; 36(4):348-53. PubMed ID: 26454490
[TBL] [Abstract][Full Text] [Related]
49. Controversies in the definition and treatment of idiopathic short stature (ISS).
Pedicelli S; Peschiaroli E; Violi E; Cianfarani S
J Clin Res Pediatr Endocrinol; 2009; 1(3):105-15. PubMed ID: 21274395
[TBL] [Abstract][Full Text] [Related]
50. [Low sensitivity of IGF-I, IGFBP-3 and urinary GH in the diagnosis of growth hormone insufficiency in slowly-growing short-statured boys. Grupo Español de Estudio de la Talla Baja].
Audí L; Antonia Llopis M; Luisa Granada M; Hermoso F; del Valle J; Dolores Rodríguez-Arnao M; Bel J; Luzuriaga C; Gallego E; Marín F;
Med Clin (Barc); 2001 Jan; 116(1):6-11. PubMed ID: 11181253
[TBL] [Abstract][Full Text] [Related]
51. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
[TBL] [Abstract][Full Text] [Related]
52. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Moore WV; Dana K; Frane J; Lippe B
Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
[TBL] [Abstract][Full Text] [Related]
53. Initiation of growth hormone therapy in idiopathic short stature: do gender differences exist?
Ben-Ari T; Lebenthal Y; Phillip M; Lazar L
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):101-4. PubMed ID: 25153217
[TBL] [Abstract][Full Text] [Related]
54. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
Richmond EJ; Rogol AD
Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
[TBL] [Abstract][Full Text] [Related]
55. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
[TBL] [Abstract][Full Text] [Related]
56. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF
J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
[TBL] [Abstract][Full Text] [Related]
57. Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS).
Park P; Cohen P
Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S13-20. PubMed ID: 16039893
[TBL] [Abstract][Full Text] [Related]
58. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
59. Leptin responses to insulin administration in children with short stature.
Zotter H; Kerbl R; Gallistl S; Aigner R; Pichler G; Borkenstein M
Metabolism; 2005 Jul; 54(7):862-5. PubMed ID: 15988693
[TBL] [Abstract][Full Text] [Related]
60. Growth outcomes in individuals with idiopathic short stature treated with growth hormone therapy.
Dahlgren J
Horm Res Paediatr; 2011; 76 Suppl 3():42-5. PubMed ID: 21912164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
